Literature DB >> 8026476

An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis.

D Herschlag1, M Khosla, Z Tsuchihashi, R L Karpel.   

Abstract

We have previously shown that a protein derived from the p7 nucleocapsid (NC) protein of HIV type-1 increases kcat/Km and kcat for cleavage of a cognate substrate by a hammerhead ribozyme. Here we show directly that the increase in kcat/Km arises from catalysis of the annealing of the RNA substrate to the ribozyme and the increase in kcat arises from catalysis of dissociation of the RNA products from the ribozyme. A peptide polymer derived from the consensus sequence of the C-terminal domain of the hnRNP A1 protein (A1 CTD) provides similar enhancements. Although these effects apparently arise from non-specific interactions, not all non-specific binding interactions led to these enhancements. NC and A1 CTD exert their effects by accelerating attainment of the thermodynamically most stable species throughout the ribozyme catalytic cycle. In addition, NC protein is shown to resolve a misfolded ribozyme-RNA complex that is otherwise long lived. These in vitro results suggest that non-specific RNA binding proteins such as NC and hnRNP proteins may have a biological role as RNA chaperones that prevent misfolding of RNAs and resolve RNAs that have misfolded, thereby ensuring that RNA is accessible for its biological functions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026476      PMCID: PMC395173          DOI: 10.1002/j.1460-2075.1994.tb06586.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  77 in total

1.  A tyrosyl-tRNA synthetase binds specifically to the group I intron catalytic core.

Authors:  Q Guo; A M Lambowitz
Journal:  Genes Dev       Date:  1992-08       Impact factor: 11.361

2.  Renaturation of complementary DNA strands mediated by purified mammalian heterogeneous nuclear ribonucleoprotein A1 protein: implications for a mechanism for rapid molecular assembly.

Authors:  B W Pontius; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Direct measurement of oligonucleotide substrate binding to wild-type and mutant ribozymes from Tetrahymena.

Authors:  A M Pyle; J A McSwiggen; T R Cech
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

4.  Rapid renaturation of complementary DNA strands mediated by cationic detergents: a role for high-probability binding domains in enhancing the kinetics of molecular assembly processes.

Authors:  B W Pontius; P Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

5.  Two interconvertible forms of tryptophanyl sRNA in E. coli.

Authors:  W J Gartland; N Sueoka
Journal:  Proc Natl Acad Sci U S A       Date:  1966-04       Impact factor: 11.205

6.  Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity.

Authors:  F Dib-Hajj; R Khan; D P Giedroc
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

7.  Kinetics of intermolecular cleavage by hammerhead ribozymes.

Authors:  M J Fedor; O C Uhlenbeck
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

8.  Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities.

Authors:  M S Swanson; G Dreyfuss
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

9.  Specificity of arginine binding by the Tetrahymena intron.

Authors:  M Yarus
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

10.  RNA annealing activities in HeLa nuclei.

Authors:  D S Portman; G Dreyfuss
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

View more
  83 in total

1.  Annealing of RNA editing substrates facilitated by guide RNA-binding protein gBP21.

Authors:  U F Müller; L Lambert; H U Göringer
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

2.  Knowledge-based analysis of microarray gene expression data by using support vector machines.

Authors:  M P Brown; W N Grundy; D Lin; N Cristianini; C W Sugnet; T S Furey; M Ares; D Haussler
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Two alternating structures of the HIV-1 leader RNA.

Authors:  H Huthoff; B Berkhout
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

4.  Small, efficient hammerhead ribozymes.

Authors:  M J McCall; P Hendry; A A Mir; J Conaty; G Brown; T J Lockett
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

5.  Identification of genes by hybrid ribozymes that couple cleavage activity with the unwinding activity of an endogenous RNA helicase.

Authors:  Hiroaki Kawasaki; Kazunari Taira
Journal:  EMBO Rep       Date:  2002-04-18       Impact factor: 8.807

6.  Nucleic acid binding properties of the nucleic acid chaperone domain of hepatitis delta antigen.

Authors:  Chun-Chung Wang; Tsung-Cheng Chang; Ching-Wen Lin; Hsiu-Ling Tsui; Page B C Chu; Bo-Shun Chen; Zhi-Shun Huang; Huey-Nan Wu
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

7.  In vitro selection of ribozymes dependent on peptides for activity.

Authors:  Michael P Robertson; Scott M Knudsen; Andrew D Ellington
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

8.  DNA condensation by the nucleocapsid protein of HIV-1: a mechanism ensuring DNA protection.

Authors:  G Krishnamoorthy; Bernard Roques; Jean-Luc Darlix; Yves Mély
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

9.  RNA chaperone StpA loosens interactions of the tertiary structure in the td group I intron in vivo.

Authors:  Christina Waldsich; Rupert Grossberger; Renée Schroeder
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

10.  Functional replacement of a domain in the rubella virus p150 replicase protein by the virus capsid protein.

Authors:  Wen-Pin Tzeng; Teryl K Frey
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.